Search Clinical Trials

589,087 trials

NCT07645703
Not Yet Recruiting
MS and Health CohortFondation Ophtalmologique Adolphe de Rothschild
NCT07644585
Not Yet RecruitingNot Applicable
A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and NeckIBA Proton Therapy, Inc.
NCT07645547
Not Yet RecruitingNot Applicable
Prophylactic Use of ciNPWT in Gynecologic LaparotomyUniversity Hospital Hradec Kralove
NCT07645417
Enrolling By InvitationNot Applicable
Maxillary Canine Retraction Using Stainless Steel and Titanium-molybdenum Alloy Wires in TAD-supported Segmental MechanicsTanzila Rafique
NCT07644208
Not Yet RecruitingPhase 2
PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative HepatectomyShanghai Zhongshan Hospital
NCT07644832
RecruitingPhase 1
An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII DeficiencyShanghai RAAS Blood Products Co., Ltd.
NCT07645365
Completed
Hemodialysis Catheter Complications in the Emergency Department Versus Hemodialysis UnitAntalya Health Sciences University
NCT07643870
Not Yet RecruitingPhase 1
Human ADME Study of [14C]-AZD1390AstraZeneca
NCT07645716
Not Yet Recruiting
Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards in Gynecologic OncologyFondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT07645235
Not Yet RecruitingPhase 1
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating WomenBiomedical Advanced Research and Development Authority
NCT07644559
RecruitingPhase 2
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerVerastem, Inc.
NCT07644312
Not Yet RecruitingPhase 2
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPGNationwide Children's Hospital
NCT07646548
Not Yet RecruitingPhase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsRegeneron Pharmaceuticals
NCT07645274
Not Yet RecruitingNot Applicable
Improving Mental Healthcare Outcomes for Minoritized Veterans Through a Peer-led, Patient Navigation Program (PARTNER-MH 2.0)Indiana University
NCT07646587
RecruitingPhase 2
A Study to Assess the Safety, Tolerability, PK and PD of WIN378 in Participants With Moderate - Severe COPDWindward Bio
NCT07645118
Not Yet RecruitingPhase 2
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal CancerDr. Te Vuong
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07644494
Completed
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: The Impact of Spontaneous Respiratory EffortJingyuan,Xu
NCT07645105
Completed
Body Weight Reduction and Metabolic/Biochemical Parameters in Overweight or ObesityMedical University of Silesia
NCT07644845
Enrolling By Invitation
MammoVerse: Clinicians Focus GroupUniversity of Central Florida